Editas Medicine to Participate in Morgan Stanley 15th Annual Global Healthcare Conference
September 05 2017 - 8:00AM
Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing
company, today announced that management will participate in a
fireside chat at the Morgan Stanley 15th Annual Global Healthcare
Conference on Tuesday, September 12, 2017 at 11:10 a.m. ET in New
York City.
A live webcast of the presentation will be available on the
Investors & Media section of the Editas website at
www.editasmedicine.com. An archived replay will be available for
approximately 30 days following the presentation.
About Editas MedicineEditas Medicine is a
leading genome editing company dedicated to treating patients with
genetically-defined diseases by correcting their disease-causing
genes. The company was founded by world leaders in genome
editing, and its mission is to translate the promise of genome
editing science into a broad class of transformative genomic
medicines to benefit the greatest number of patients.
Media Contact
Cristi Barnett
Editas Medicine, Inc.
(617) 401-0113
cristi.barnett@editasmed.com
Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083
mark.mullikin@editasmed.com
Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
From Apr 2023 to Apr 2024